Medical Advisory Panel

Dr. Pintar
Dr. Tom Pintar
Dynamic board certified Private Practice Nephrologist

Dynamic board certified Private Practice Nephrologist with 12 years of clinical experience caring for patients with CKD (Chronic Kidney Disease), Hypertension, Diabetes, and after renal transplant in Fort Wayne, Indiana. Also, a 22-year survivor with Type I Diabetes. Active recreational athlete with accomplishments ranging from competing in Ironman Triathlon, Ultra marathons, and Ultra-cycling races including the RAAM (Race Across America). Strong proponent of fitness as a means to better control chronic illness and contribute to an improved quality of life. Active in encouraging patients to participate in regular fitness activities as a “prescription” to better health.

Dr. Wong
Craig Wong MD MPH.
Department of Pediatrics, Division of Pediatric Nephrology

Education and Honors:
1989, B.S., Biology, University of Washington, Seattle, WA
1980, MD., University of Washington,
1997 Pediatric Residency, Oregon Health Sciences University, Portland, OR.
2000 Pediatric Subspecialty in Pediatric Nephrology University of Washington
2000 MPH in Epidemiology, University of Washington.
2000-2009 Assistant Professor Pediatrics, Div. of Pediatric Nephrology at UNM.
2009-present Associate Professor Pediatrics, Div. Pediatric Nephrology at UNM
2003-present Scientific Steering Committee Member of the Chronic Kidney Disease in Children Study (CKiD)

Professional Summary
Craig Wong came to the University of New Mexico Department of Pediatrics in the year 2000. The UNM Division of Pediatric Nephrology serves children throughout the region with hypertension, kidney disease. Children who need or have received renal transplant, children on dialysis, and children requiring monitoring for congenital and acquired renal disease, are all followed by the three physicians in this Division of UNM Pediatrics.
The main emphasis of Dr. Wong’s research is the epidemiology of chronic kidney disease (CKD) in children and health outcomes in this population. Since 2003, he has been a member of the Scientific Steering Committee of the Chronic Kidney Disease in Children (CKiD) Study, funded by the National Institutes of Health. The CKiD Study is a multi-center prospective study that includes 43 centers in the United States and Canada funded by the NIDDK. CKiD is gathering detailed epidemiologic information on 567 children with mild to moderate chronic kidney disease. The specific aims of the CKiD study are to (1) identify novel and traditional risk factors for renal disease progression; (2) characterize the impact of decline in kidney function on neurodevelopment, cognitive abilities, and behavior; (3) identify the prevalence and evolution of cardiovascular disease risk factors in children with CKD; and (4) examine the effects of decline in kidney function on growth and the consequences of growth failure in children with CKD. The study gathers measurements of kidney function, blood pressure, and other highly detailed information.
http://www.statepi.jhsph.edu/ckid/